Publications by authors named "Daniel Wehrung"

Claim this Profile
A
Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug.
Dharani Manickavasagam, Daniel Wehrung, Elaheh A Chamsaz, Matthew Sanders, Rachida Bouhenni

Eur J Pharm Biopharm· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gelucire-stabilized nanoparticles as a potential DNA delivery system.
Moses O Oyewumi, Daniel Wehrung, Prabodh Sadana

Pharm Dev Technol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells.
Moses O Oyewumi, Dharani Manickavasagam, Kimberly Novak, Daniel Wehrung, Nikola Paulic

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Werner Geldenhuys, Daniel Wehrung, Anastasia Groshev, Anjali Hirani, Vijaykumar Sutariya

Pharm Dev Technol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation and photoirradiation parameters that influenced photoresponsive drug delivery using alkoxylphenacyl-based polycarbonates.
Daniel Wehrung, Elaheh A Chamsaz, Abraham Joy, Moses O Oyewumi

Eur J Pharm Biopharm· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging lung cancer therapeutic targets based on the pathogenesis of bone metastases.
Moses O Oyewumi, Adnan Alazizi, Daniel Wehrung, Rami Manochakian, Fayez F Safadi

Int J Cell Biol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermoreversible gel for delivery of activin receptor-like kinase 5 inhibitor SB-505124 for glaucoma filtration surgery.
Vijaykumar Sutariya, Nicholas Miladore, Werner Geldenhuys, Deepak Bhatia, Daniel Wehrung

Pharm Dev Technol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contributory roles of innate properties of cetyl alcohol/gelucire nanoparticles to antioxidant and anti-inflammation activities of quercetin.
Lipeng Bi, Daniel Wehrung, Moses O Oyewumi

Drug Deliv Transl Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor efficacy and tolerability of systemically administered gallium acetylacetonate-loaded gelucire-stabilized nanoparticles.
Daniel Wehrung, Lipeng Bi, Werner J Geldenhuys, Moses O Oyewumi

J Biomed Nanotechnol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biocompatibility and in vivo tolerability of a new class of photoresponsive alkoxylphenacyl-based polycarbonates.
Daniel Wehrung, Shuangyi Sun, Elaheh A Chamsaz, Abraham Joy, Moses O Oyewumi

J Pharm Sci· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsions.
Daniel Wehrung, Werner J Geldenhuys, Moses O Oyewumi

Colloids Surf B Biointerfaces· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a novel RP-HPLC method for the analysis of reduced glutathione.
Vijaykumar Sutariya, Daniel Wehrung, Werner J Geldenhuys

J Chromatogr Sci· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biocompatibility, efficacy and biodistribution of Gelucire-stabilized nanoparticles engineered for docetaxel delivery.
Daniel Wehrung, Werner J Geldenhuys, Lipeng Bi, Moses O Oyewumi

J Nanosci Nanotechnol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effect of novel gallium compounds and efficacy of nanoparticle-mediated gallium delivery in lung cancer.
Daniel Wehrung, Moses O Oyewumi

J Biomed Nanotechnol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis